Biophy Review (April 2026)
We are BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using our patent-pending AI drug development technology. BioPhy is pioneering new approaches that will unleash a wave of drug discovery innovation. BioPhy technology is designed
We are BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using our patent-pending AI drug development technology. BioPhy is pioneering new approaches that will unleash a wave of drug discovery innovation. BioPhy technology is designed
What is Biophy's Revenue?
Biophy's estimated revenue is $3M.
What does Biophy do?
We are BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using our patent-pending AI drug development technology. BioPhy is pioneering new approaches that will unleash a wave of drug discovery innovation. BioPhy technology is designed
Technology detection powered by advanced web analysis
Powered byTechlist.aiStaydomio
Immunomedics
Vettery
Learn about LHH, with our global network of colleagues who bring local knowledge and experience to support millions of people across the full talent lifecycle.More
Livetiles
Sema4
The #1 genomic test, preferred by more than 80% of genetic and pediatric providers1. Delivering precise, fast, and actionable diagnoses.More